Basit öğe kaydını göster

dc.contributor.authorSezgin, Fikriye Milletli
dc.contributor.authorOnarer, Pelin
dc.contributor.authorÜnalan, Tuğçe
dc.date.accessioned2024-03-12T19:38:54Z
dc.date.available2024-03-12T19:38:54Z
dc.date.issued2023
dc.identifier.issn2619-9203
dc.identifier.urihttps://doi.org/10.46332/aemj.1061193
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1163973
dc.identifier.urihttps://hdl.handle.net/20.500.12450/3352
dc.description.abstractPurpose: This study aimed to screen the patients admitted to our hospital for SARS-CoV-2 specific antibodies after a PCR test and understand the local serological profile. Materials and Methods: The patients tested for anti-SARS-CoV-2 IgG and/or IgM between January-June 2021 were included in the study. SARS-CoV-2 PCR test was performed simultaneously. Results: Either IgM or IgG alone was requested in 123 of 725 patients, and IgM and IgG together in 602. The PCR test was positive in 40 (13%) of 304 (42%) patients who had a PCR test after 30 days of the serology request. Of these PCR-positive patients, 60% had IgM and IgG antibodies together, whereas among 204 PCR-negative patients, 64% tested negative for IgM and IgG. 58% of the tests were ordered without a PCR request. The period between PCR and serology testing was as follows: 233 (76.6%) in 7 days, 27 (8.8%) in 8-14 days, 7 (2.3%) in 15-21 days, and 37 (12.3%) in 22-30 days. 117 (38.5%) of the requests were made simultaneously. Conclusion: WHO recommends that serology testing should be performed after the 1st and 3-4th week of the initial PCR test. The high rate of inappropriate testing demonstrates a lack of algorithms. The use of serological tests is recommended in conjunction with nucleic acid tests but not to be used alone in the diagnosis of COVID-19. Our results demonstrated the high rate of unnecessary requests for serology testing to determine the antibody response against SARS-CoV-2 vaccines.en_US
dc.language.isoengen_US
dc.relation.ispartofAhi Evran Medical Journalen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleInvestigation of COVID-19 Serology in a Tertiary Care Centeren_US
dc.typearticleen_US
dc.departmentAmasya Üniversitesien_US
dc.identifier.volume7en_US
dc.identifier.issue1en_US
dc.identifier.startpage83en_US
dc.identifier.endpage88en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.trdizinid1163973en_US
dc.identifier.doi10.46332/aemj.1061193
dc.department-tempAmasya Üniversitesi, Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Amasya, Türkiye Amasya Üniversitesi, Sabuncuoğlu Şerefeddin Eğitim ve Araştırma Hastanesi, Tıbbi Mikrobiyoloji Kliniği, Amasya, Türkiye Amasya Üniversitesi, Sabuncuoğlu Şerefeddin Eğitim ve Araştırma Hastanesi, Tıbbi Mikrobiyoloji Kliniği, Amasya, Türkiyeen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster